Safety and efficacy of sofosbuvir plus ledipasvir and sofosbuvir plus daclatasvir in thalassemic adolescent patients with chronic hepatitis C: A single center observational study

被引：0
|
作者：
Sawant, Prabha [1 ]
Patel, Ruchir [1 ]
Pandey, Vikas [1 ]
Ingle, Meghraj [1 ]
机构：
[1] Lokmanya Tilak Municipal Med Coll & Hosp, Dept Gastroenterol, Bombay, Maharashtra, India
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-0128
引用
收藏
页码：159 / 159
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis
    El Kassas, Mohamed
    Abdeen, Nermeen
    Omran, Dalia
    Alboraie, Mohamed
    Salaheldin, Mohamed
    Eltabbakh, Mohamed
    Farghaly, Rasha
    Emadeldeen, Mohammed
    Afify, Shimaa
    Sweedy, Ahmad
    Ghalwash, Ahmed
    Abbass, Amr
    Ezzat, Sameera
    Tahoon, Marwa
    ELshazly, Helmy M.
    Hamdy, Hassan
    Omar, Heba
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E877 - E882
  • [2] Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis
    El Kassas, Mohamed
    Abdeen, Nermeen
    Omran, Dalia
    Alboraie, Mohamed
    Salaheldin, Mohamed
    Eltabbakh, Mohamed
    Farghaly, Rasha
    Emadeldeen, Mohammed
    Afify, Shimaa
    Sweedy, Ahmad
    Ghalwash, Ahmed
    Abbass, Amr
    Ezzat, Sameera
    Tahoon, Marwa
    ELshazly, Helmy M.
    Hamdy, Hassan
    Omar, Heba
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E877 - E882
  • [3] Safety and Efficacy of Sofosbuvir Plus Ribavirin and Sofosbuvir Plus Daclatasvir With or Without Ribavirin Combinations in Children and Adolescents With Chronic Hepatitis C
    Hassan, Adil
    Bughio, Ubedullah
    Bhatti, Rehmatullah
    Ali, Mashooque
    Jamali, Laraib
    Sadik, Muhammad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S592 - S592
  • [4] Compare the Efficacy of Sofosbuvir Plus Ribavirin Verus Sofosbuvir Plus Daclatasvir in Patients with Chronic C Hepatitis Genotype 2 Infection
    Chang, Kuo-Chin
    Hu, Tsung-Hui
    Chen, Chien Hung
    Wang, Jing-Houng
    HEPATOLOGY, 2018, 68 : 586A - 586A
  • [5] Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders
    Walsh, C. E.
    Workowski, K.
    Terrault, N. A.
    Sax, P. E.
    Cohen, A.
    Bowlus, C. L.
    Kim, A. Y.
    Hyland, R. H.
    Han, B.
    Wang, J.
    Stamm, L. M.
    Brainard, D. M.
    McHutchison, J. G.
    von Drygalski, A.
    Rhame, F.
    Fried, M. W.
    Kouides, P.
    Balba, G.
    Reddy, K. R.
    HAEMOPHILIA, 2017, 23 (02) : 198 - 206
  • [6] Ledipasvir/Sofosbuvir versus Daclatasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Genotype 4 Patients
    Abdelaty, Lamiaa N.
    Elnaggar, Ahmed A.
    Said, Amira A.
    Hussein, Raghda R. S.
    CURRENT DRUG SAFETY, 2020, 15 (01) : 53 - 60
  • [7] Effect of sofosbuvir plus daclatasvir for treatment of chronic hepatitis C on patients with psoriasis
    Ismail, Waleed A.
    Yousef, Ayman E.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (08) : 1025 - 1029
  • [8] An evaluation of ledipasvir plus sofosbuvir for the treatment of chronic hepatitis C infection
    Balatow, Pearson
    Sandlin, Amber
    Cory, Theodore James
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (14) : 1839 - 1846
  • [9] Efficacy and Safety of Sofosbuvir and Ledipasvir for Hepatitis C in Kidney Transplant Recipients: A Single-center Retrospective Observational Study
    Artan, Ayse Serra
    Mirioglu, Safak
    Istemihan, Zulal
    Aksoy, Elif
    Dirim, Ahmet Burak
    Cavus, Bilger
    Oto, Ozgur Akin
    Cifcibasi-Ormeci, Asli
    Besisik, Fatih
    Caliskan, Yasar
    Ozturk, Savas
    Yazici, Halil
    Kaymakoglu, Sabahattin
    Turkmen, Aydin
    BALKAN MEDICAL JOURNAL, 2023, 40 (03) : 182 - 187
  • [10] Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study
    Kawakami, Yoshiiku
    Ochi, Hidenori
    Hayes, Clair Nelson
    Imamura, Michio
    Tsuge, Masataka
    Nakahara, Takashi
    Katamura, Yoshio
    Kohno, Hiroshi
    Kohno, Hirotaka
    Tsuji, Keiji
    Takaki, Shintaro
    Mori, Nami
    Honda, Yohji
    Arataki, Keiko
    Takahashi, Shoichi
    Kira, Shinsuke
    Tamura, Toru
    Masuda, Kazunari
    Nakamura, Toshio
    Kikkawa, Masaya
    Chayama, Kazuaki
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (04) : 548 - 556
12345